The report covers forecast and analysis for the antithrombin market on a global and regional level. The study provides historic data of 2016 along with a forecast from 2017 to 2022 based revenue (USD Million). The study includes drivers and restraints for the antithrombin market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the antithrombin market on a global level.


In order to give the users of this report a comprehensive view of the antithrombin market, we have to include competitive landscape and analysis of Porters Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein source, application segments, and dosage form segments are benchmarked based on their market size, growth rate, and general attractiveness.


The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions mergers, new technology launch, agreements, partnerships, collaborations joint ventures, research development, technology and regional expansion of major participants involved in the market on the global and regional basis. Moreover, the study covers price trend analysis, the product portfolio of various companies according to the region.


The study provides a decisive view on the antithrombin market by segmenting the market based on source, application, dosage form, and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2014 to 2022. Based on the source the market is segmented into human, and goat milk. Key application covered under this study includes diagnostics, therapeutics, and research. By dosage form, the market is segmented into liquid and lyophilized.


The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America and the Middle East Africa with its further bifurcation into major countries including the U.S. Germany, France, UK, China, Japan, India, and Brazil. This segmentation includes demand for antithrombin based on source, application, and dosage form in all the regions and countries.


The report also includes detailed profiles of end players such as Grifols, rEVO Biologics Inc., Shire plc., Kedrion S.p.A., CSL Limited, Scripps Laboratories Inc., and Lee Biosolutions among others.


Global Antithrombin Market: Source Segment Analysis

Human

Goat Milk

Global Antithrombin Market: Application Segment Analysis

Diagnostics

Therapeutics

Research

Global Antithrombin Market: Dosage Form Segment Analysis

Liquid

Lyophilized

Global Antithrombin Market: Regional Segment Analysis

North America


U.S.

Europe


UK

France

Germany

Asia Pacific


China

Japan

India

Latin America


Brazil

Middle East and Africa